STONY BROOK, N.Y., July 31 /PRNewswire-FirstCall/ -- Applied DNA
Sciences, Inc. (OTC Bulletin Board: APDN), a DNA security solutions
company, today announced that its co-development project with Stony Brook
University has been extended for at least a year based upon progress
generated since the project began in February 2006. The initial grants
funded the further development of APDN's DNA library and the completion of
additional prototypes that will allow APDN to extend its platform to
additional industries. APDN uses DNA encryption to authenticate products
and identify counterfeits. Funding awarded to this project by the
University's Center for Biotechnology ("Center"), a New York State Center
for Advanced Technology, now totals $158,011.54.
Dr. Clinton T. Rubin, Director, Center for Biotechnology and Professor
and Chair, Department of Biomedical Engineering, Stony Brook University,
stated, "We are very pleased to continue to facilitate the collaboration
between the Center and Applied DNA Sciences. This grant will help continue
to provide resources and support to fuel the growth and commercialization
of forensic- based technologies."
Leading this project on behalf of the Center is Dr. Sanford Simon,
Professor of Biochemistry, Cell Biology, and Pathology, Stony Brook
University, and a director of APDN, "The first stage of this project, which
is essentially creating a library of unique sequences of plant DNA, has
"Thanks to the support from the Center for Biotechnology for this
project, we are able to extend our uses of the company's unique plant
chimers into new commercial markets that have been heretofore inaccessible
for DNA markings. We are now expanding our reach from consumer products and
art to pharmaceuticals. The first grant has helped APDN to assemble
prototypes of products that we can demonstrate to our clients," stated Dr.
Benjamin Liang, Strategic Technology Officer for Applied DNA Sciences.
About Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (APDN) develops proprietary DNA-embedded
security solutions that use plant DNA to verify authenticity and protect
corporate and government agencies from counterfeiting, fraud, piracy,
product diversion, identity theft and unauthorized intrusion into physical
plant and databases. Our common stock is registered under Section 12(g) of
the Securities Exchange Act of 1934 and is listed on the Over-The-Counter
Bulletin Board under the symbol "APDN". Contact: MeiLin Wan, Applied DNA
Sciences, Inc., 25 Health Sciences Drive, Stony Brook, New York 11790; Tel:
631-444- 6370; Fax: 631-444.8848 http://www.ADNAS.com.
The statements made by Applied DNA Sciences, Inc. may be
forward-looking in nature and are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements describe the Company's future plans,
projections, strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are beyond the
control of Applied DNA Sciences, Inc. Actual results could differ
materially from those projected due to changes in interest rates, market
competition, changes in the local and national economies, and various other
factors detailed from time to time in Applied DNA Sciences' SEC reports and
filings, including our Annual Report on Form 10-KSB, filed on January 12,
2006, our subsequent Quarterly Reports on Form 10-QSB, and our Current
Reports on Form 8-K. The Company undertakes no obligation to update
publicly any forward-looking statements to reflect new information, events
or circumstances after the date hereof to reflect the occurrence of
SOURCE Applied DNA Sciences, Inc.